Muntadhar Al Moosawi Gives A Talk on Chromogenic FVIII in Hemophilia A at WHX Labs Dubai
Muntadhar Al Moosawi, Consultant Hematopathology and Head of Transfusion Services and Coagulation Laboratory, shared on LinkedIn:
”Honored to be a speaker at WHX Labs Dubai, where I presented on the clinical utility of the chromogenic Factor VIII assay in hemophilia A.
My talk focused on the well-recognized discrepancies between one-stage clot-based and chromogenic assays—particularly in mild and moderate hemophilia—and the practical implications for accurate diagnosis, monitoring, and therapeutic decision-making in the era of extended half-life products and novel agents.
It was a privilege to engage with colleagues and discuss how optimized assay selection and interpretation can directly impact patient care and laboratory best practices.
Thanks to the Dr. Eiman Alzaabi and Dr. Chethan Belludi for the invitation.”
Stay updated with Hemostasis Today.
-
May 27, 2026, 14:30Stacey Black Watson: A Meaningful Gathering Focused on Genetic Aortic and Vascular Conditions
-
May 27, 2026, 14:27Abdullah Mohsin: Possible Nursing Interventions for a Patient with DVT
-
May 27, 2026, 14:21Emmanuel J Favaloro: 100 Years of Von Willebrand disease
-
May 27, 2026, 14:20Noemy E. Diaz-Burgos: A Memorable Opening to the WFH Congress in Kuala Lumpur
-
May 27, 2026, 14:14Urgent Call for A and O Blood Donations! – Australian Red Cross Lifeblood
-
May 27, 2026, 14:06Augustina Isioma Ikusemoro: Why Routine Platelet Transfusion Is Not Always Recommended in Dengue
-
May 27, 2026, 13:56Suzan Osman: The Major Types of Intracranial Hemorrhage in Clinical Practice
-
May 27, 2026, 13:55Raimundo C. Santos: The Main Aggressors of the Aorta and What These Lead to
-
May 27, 2026, 13:54Pooja Choradia: 2026 Acute Pulmonary Embolism Clinical Guidelines